Bone marrow cells may significantly reduce risk of second heart attack

Dec 08, 2009

Cells from heart attack survivors' own bone marrow reduced the risk of death or another heart attack when they were infused into the affected artery after successful stent placement, according to research reported in the American Heart Association journal Circulation: Heart Failure.

Benefits found early in the Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial could last for at least two years, researchers said.

"More research is needed, but this gives us a hint of what might be possible with this new treatment — prevention of another attack and of rehospitalization for heart failure, both life-threatening complications," said Birgit Assmus, M.D., first author of the study and assistant professor of cardiology at J.W. Goethe University in Frankfurt, Germany.

Researchers conducted the study at 17 centers in Germany and Switzerland. They randomized 101 heart attack survivors to receive a solution including progenitor cells from their own bone marrow. The other 103 patients received a solution.

Progenitor cells, like , are early-stage cells. They are still able to differentiate into various types of certain adult cells - but not exactly like a cellular "blank slate" seen with stem cells. Rather, are more specific than stem cells and are further along in the process towards forming the type of adult cell they will become.

Researchers infused cells or placebo into the artery that triggered patients' heart attacks three to seven days after undergoing reperfusion therapy. "The goal of this study was to prevent heart failure by enhancing new vessel growth and perfusion of the surviving tissue," Assmus said.

Among the study's results:

  • At two years, no patients from the cell group had suffered a while seven patients from the placebo group had — a statistically significant difference.
  • Compared with placebo patients, cell-infused patients were less likely to die (three vs. eight in placebo group), need new revascularizations (25 vs. 38), or be rehospitalized for (one vs. five).
"Large, randomized trials are urgently needed to assess the effects of progenitor-cell therapy in patients with heart attacks," Assmus said.

Source: American Heart Association (news : web)

Explore further: Critically ill ICU patients lose almost all of their gut microbesand the ones left aren't good

add to favorites email to friend print save as pdf

Related Stories

Stem cells to be injected into the heart

Aug 26, 2005

The University of Pittsburgh Medical Center will begin a clinical trial to determine the feasibility of injecting a patient's own stem cells into the heart.

Stem cells to repair damaged heart muscle

Jun 22, 2007

In the first trial of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery.

Recommended for you

Infant cooing, babbling linked to hearing ability

5 hours ago

Infants' vocalizations throughout the first year follow a set of predictable steps from crying and cooing to forming syllables and first words. However, previous research had not addressed how the amount ...

Developing 'tissue chip' to screen neurological toxins

6 hours ago

A multidisciplinary team at the University of Wisconsin-Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that ...

Gene mutation discovered in blood disorder

10 hours ago

An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which ...

Airway muscle-on-a-chip mimics asthma

12 hours ago

The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people ...

User comments : 0